Literature DB >> 21686224

Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP).

John R Sedor1, Sethu M Madhavan, Jane H Kim, Martha Konieczkowski.   

Abstract

Normal function of the glomerular filtration barrier requires wild-type differentiation of the highly specialized glomerular epithelial cell, the podocyte. Podocytes express three distinct domains, consisting of a cell body, primary processes, and secondary foot processes (FP). These FP express slit diaphragms, which are highly specialized cell-cell contacts critical for filtration-barrier function. Foot processes are dynamic structures that reorganize within minutes through actin cytoskeletal rearrangement. Glomerular diseases are characterized by a persistent simplification in podocyte domain structure with loss of FP, a phenotype described as FP effacement. The generation of such phenotypic plasticity requires that signaling pathways in subcellular compartments be integrated dynamically for a cell to respond appropriately to information flow from its microenvironment. We have identified a LIM-domain-containing protein, Wilm's tumor interacting protein (WTIP), that regulates podocyte actin dynamics to maintain stable cell contacts. After glomerular injury, the WTIP molecule shuttles to the podocyte nucleus in response to changes in slit-diaphragm assembly, and changes gene transcription to permit podocyte remodeling. Defining regulatory pathways of podocyte differentiation identifies novel, druggable targets for chronic kidney diseases characterized by glomerular scarring.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21686224      PMCID: PMC3116355     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  33 in total

1.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

Authors:  D Kerjaschki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

3.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 4.  The complex life of WT1.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Andreas Schedl
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

5.  Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.

Authors:  Y H Kim; M Goyal; D Kurnit; B Wharram; J Wiggins; L Holzman; D Kershaw; R Wiggins
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

6.  Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome.

Authors:  Rainer G Ruf; Michael Schultheiss; Anne Lichtenberger; Stephanie M Karle; Isabella Zalewski; Bettina Mucha; Anne Schulze Everding; Thomas Neuhaus; Ludwig Patzer; Christian Plank; Johannes P Haas; Fatih Ozaltin; Anita Imm; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

7.  Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Authors:  Jochen Reiser; Gero von Gersdorff; Martin Loos; Jun Oh; Katsuhiko Asanuma; Laura Giardino; Maria Pia Rastaldi; Novella Calvaresi; Haruko Watanabe; Karin Schwarz; Christian Faul; Matthias Kretzler; Anne Davidson; Hikaru Sugimoto; Raghu Kalluri; Arlene H Sharpe; Jordan A Kreidberg; Peter Mundel
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.

Authors:  Manakan B Srichai; Martha Konieczkowski; Aparna Padiyar; David J Konieczkowski; Amitava Mukherjee; Patrick S Hayden; Sweta Kamat; M Ashraf El-Meanawy; Shenaz Khan; Peter Mundel; Sean Bong Lee; Leslie A Bruggeman; Jeffrey R Schelling; John R Sedor
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

9.  The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.

Authors:  Chi-yuan Hsu; Eric Vittinghoff; Feng Lin; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2004-07-20       Impact factor: 25.391

10.  Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane.

Authors:  Yamato Kikkawa; Ismo Virtanen; Jeffrey H Miner
Journal:  J Cell Biol       Date:  2003-04-07       Impact factor: 10.539

View more
  5 in total

1.  IQGAP1 regulates actin cytoskeleton organization in podocytes through interaction with nephrin.

Authors:  Yipeng Liu; Wei Liang; Yingjie Yang; Yangbin Pan; Qian Yang; Xinghua Chen; Pravin C Singhal; Guohua Ding
Journal:  Cell Signal       Date:  2015-01-31       Impact factor: 4.315

2.  The Players: Cells Involved in Glomerular Disease.

Authors:  A Richard Kitching; Holly L Hutton
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

Review 3.  Podocyte dedifferentiation: a specialized process for a specialized cell.

Authors:  Carl James May; Moin Saleem; Gavin Iain Welsh
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-01       Impact factor: 5.555

4.  Comprehensive and Systematic Analysis of Gene Expression Patterns Associated with Body Mass Index.

Authors:  Paule V Joseph; Rosario B Jaime-Lara; Yupeng Wang; Lichen Xiang; Wendy A Henderson
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

5.  Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation.

Authors:  Xuejuan Li; Fangrui Ding; Suxia Wang; Baihong Li; Jie Ding
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.